It’s time to review our dosing with ketorolac for acute pain management.
News from the FDA/CDC
The treatment binds to calcitonin gene-related peptide and is the first therapy to reduce the frequency of episodic cluster headache attacks.
MILWAUKEE – The significant pain reductions with this technique came as a surprise to researchers.
TORONTO – “I think there is a signal in this study.” – Dr. Philip G. Conaghan
Topics include: No 1 tx for fibromyalgia • Mood & behavior in kids • Biomarkers for VTE risk • Exercise & concussion recovery • Survival...
SAN FRANCISCO – It’s best to ask people what they’re using, and to counsel new users – especially the elderly – to start low and go slow, Dr....
SEATTLE – In a novel study, about half of patients with multiple sclerosis reported clinically significant symptoms of depression or pain, and...
Compared with outpatient clinics, prescription rate is more than six times higher in the emergency department.
TORONTO – The nerve growth factor inhibitor separated from placebo in the first 3-5 days in a phase 3 randomized, controlled trial.
Following implementation of EMR alerts in New Jersey, a greater decline in the morphine milligram equivalent per prescription was seen in New...